The power of combining adoptive cell therapy (ACT) and pathogen-boosted vaccination to treat solid tumors
Recent advancements in adoptive cell therapy (ACT) are opening up new frontiers for cancer immunotherapy. CAR T cells targeting CD19 have emerged as a remarkable T cell-based therapy for the successful treatment of certain types of leukemia and lymphomas. Despite these clinical successes, as well as...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis Group
2017-10-01
|
| Σειρά: | Human Vaccines & Immunotherapeutics |
| Θέματα: | |
| Διαθέσιμο Online: | http://dx.doi.org/10.1080/21645515.2017.1345833 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|